Deltanoid Pharmaceuticals' Series B Round

Deltanoid Pharmaceuticals raised a round of funding on December 24, 2007.

Deltanoid Pharmaceuticals is a clinical stage biopharmaceutical company with a vision focused on unlocking the power of the vitamin D receptor (VDR) to transform health outcomes for patients with dise…

Articles about Deltanoid Pharmaceuticals' Series B Round: